San Francisco, California, June 16, 2017: Increasing awareness programs through conferences and industry meets along with the government funding are anticipated to fuel the global whole exome sequencing market in the coming years. TMR Research prognosticates a rapid growth on account of high investments by several companies, increasing focus on research and development activities. The report is titled” Whole Exome Sequencing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017-2025”.
Technological advancements in sequencing systems, collaborations and partnerships amongst leading manufacturers, and increased investments on research and developments activities are anticipated to boost the global whole exome sequencing market in the coming years. Rising incidents of cancer and several infectious diseases are also propelling the growth of the global whole exome sequencing market. In addition, reduced cost of sequencing and promotion of WES technology are the major factor influencing the market growth positively. However, lack of skilled professionals and major dependence on the government authorities for the approvals are the factors holding the growth of the global whole exome sequencing market.
The global whole exome sequencing market can be segmented on the basis of technology, end user, product and services, applications, and geography. The market, by technology, comprises sequencing by synthesis and sequencing in semiconductor. Created on end users, the global whole exome sequencing market can be segmented into government institutions, hospitals and clinics, research centers, academic institutions, and pharmaceutical companies. Government institutions and research centers has been leading share holder of the whole exome sequencing market. On the basis of applications, diagnostics, animal and plant research, drug discovery and development, and personalized medicine are the segments of the whole exome sequencing market.
Geographically, the global whole exome sequencing market can be segmented into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. North America has been the leading market for whole exome sequencing and is likely to grow substantially in the coming years. The Asian market is anticipated to raise at higher growth rate owing to factors such as increased government funding and rising use of exome sequencing. Europe is a leading region for diagnosing and treatment of HIV and cancer diseases. Growing use of exome sequencing in sickness investigation and improved government policies are the issues propelling the Middle East and Africa market.
A detail assessment has been carried out in order to figure the various attributes influencing the market, such as drivers, restraints, trends, challenges, and opportunities. Key players operating in the global market has been profiled to give a clear understanding to the readers.
The report foresees Eurofins Genomics, GENEWIZ Inc., Agilent Technologies, Roche NimbleGen Inc., Thermo Fisher Scientific Inc., Illumina Inc., BGIS, Knome Inc., and Macrogen Inc. as the leading players in the global whole exome sequencing market.